Dear Nicole,
my apologies, I was given information that Roche will no longer support the 454. Please accept my sincerest apology for the confusion.
Header Leaderboard Ad
Collapse
The End for 454
Collapse
Announcement
Collapse
No announcement yet.
X
-
Hi Aniki,
We are committed to providing our 454 instruments, parts, reagents, consumables, service and support for all our 454 products currently on the market over the next three years until mid-2016. We will also be offering new updates, including longer reads for the GS Junior System (both random fragment and amplicon libraries),
If you have any specific questions or concerns I encourage you to reach out to your local Roche service representative.
Best Regards,
Nicole
Senior Support Specialist
454 Life Sciences, A Roche Company
Leave a comment:
-
Tags: None
Latest Articles
Collapse
-
by seqadmin
Amplicon sequencing is a targeted approach that allows researchers to investigate specific regions of the genome. This technique is routinely used in applications such as variant identification, clinical research, and infectious disease surveillance. The amplicon sequencing process begins by designing primers that flank the regions of interest. The DNA sequences are then amplified through PCR (typically multiplex PCR) to produce amplicons complementary to the targets. RNA targets...-
Channel: Articles
03-21-2023, 01:49 PM -
-
by seqadmin
Targeted sequencing is an effective way to sequence and analyze specific genomic regions of interest. This method enables researchers to focus their efforts on their desired targets, as opposed to other methods like whole genome sequencing that involve the sequencing of total DNA. Utilizing targeted sequencing is an attractive option for many researchers because it is often faster, more cost-effective, and only generates applicable data. While there are many approaches...-
Channel: Articles
03-10-2023, 05:31 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Yesterday, 11:44 AM
|
0 responses
10 views
0 likes
|
Last Post
by seqadmin
Yesterday, 11:44 AM
|
||
Started by seqadmin, 03-24-2023, 02:45 PM
|
0 responses
18 views
0 likes
|
Last Post
by seqadmin
03-24-2023, 02:45 PM
|
||
Started by seqadmin, 03-22-2023, 12:26 PM
|
0 responses
22 views
0 likes
|
Last Post
by seqadmin
03-22-2023, 12:26 PM
|
||
Started by seqadmin, 03-17-2023, 12:32 PM
|
0 responses
19 views
0 likes
|
Last Post
by seqadmin
03-17-2023, 12:32 PM
|
Leave a comment: